Loading…
Company strengthens intellectual property portfolio.
Beyond Air, Inc. (Nasdaq: XAIR) announced it has been granted a patent by the United States Patent and Trademark Office. The patent enhances the company's intellectual property portfolio, providing additional protection for its innovative medical device technologies.
The newly granted patent is a significant addition to Beyond Air's existing patents, reinforcing its competitive position in the healthcare industry. With a free float of 703,354 shares, the company continues to focus on advancing its medical device offerings.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.